Pacemaker Electrodes To Switch Approval Processes At FDA
The U.S. Food and Drug Administration announced a final rule on Thursday that will require cardiovascular permanent pacemaker electrode manufacturers to submit new information to the regulator to keep their products...To view the full article, register now.
Already a subscriber? Click here to view full article